143 related articles for article (PubMed ID: 12419690)
21. Assessment of estrogenic activity of natural compounds using improved E-screen assay.
Tian CY; Hu CQ; Xu G; Song HY
Acta Pharmacol Sin; 2002 Jun; 23(6):572-6. PubMed ID: 12060535
[TBL] [Abstract][Full Text] [Related]
22. Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues.
Schmitt E; Dekant W; Stopper H
Toxicol In Vitro; 2001; 15(4-5):433-9. PubMed ID: 11566575
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the intracellular calcium level in mammalian cells caused by 17beta-estradiol, different phytoestrogens and the anti-estrogen ICI 182780.
Dopp E; Vollmer G; Hahnel C; Grevesmühl Y; Schiffmann D
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):57-64. PubMed ID: 10215038
[TBL] [Abstract][Full Text] [Related]
24. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin.
Zierau O; Gester S; Schwab P; Metz P; Kolba S; Wulf M; Vollmer G
Planta Med; 2002 May; 68(5):449-51. PubMed ID: 12058324
[TBL] [Abstract][Full Text] [Related]
25. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
Jeng MH; Langan-Fahey SM; Jordan VC
Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
[TBL] [Abstract][Full Text] [Related]
26. Flavonoid effects relevant to cancer.
Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
[TBL] [Abstract][Full Text] [Related]
27. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica.
Lee YS; Park JS; Cho SD; Son JK; Cherdshewasart W; Kang KS
J Vet Sci; 2002 Dec; 3(4):273-7. PubMed ID: 12819377
[TBL] [Abstract][Full Text] [Related]
28. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
Chen X; Anderson JJ
Nutr Cancer; 2001; 41(1-2):165-71. PubMed ID: 12094620
[TBL] [Abstract][Full Text] [Related]
29. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
30. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
[TBL] [Abstract][Full Text] [Related]
31. Estrogen-like activities of saikosaponin-d in vitro: a pilot study.
Wang P; Ren J; Tang J; Zhang D; Li B; Li Y
Eur J Pharmacol; 2010 Jan; 626(2-3):159-65. PubMed ID: 19819234
[TBL] [Abstract][Full Text] [Related]
32. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.
Yoon K; Pallaroni L; Stoner M; Gaido K; Safe S
J Steroid Biochem Mol Biol; 2001 Jul; 78(1):25-32. PubMed ID: 11530281
[TBL] [Abstract][Full Text] [Related]
33. Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.
Levenson AS; Catherino WH; Jordan VC
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):261-8. PubMed ID: 9219916
[TBL] [Abstract][Full Text] [Related]
34. Estrogenic effects of fusarielins in human breast cancer cell lines.
Sondergaard TE; Klitgaard LG; Purup S; Kobayashi H; Giese H; Sørensen JL
Toxicol Lett; 2012 Nov; 214(3):259-62. PubMed ID: 22982765
[TBL] [Abstract][Full Text] [Related]
35. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
36. Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer.
Gallo D; Mantuano E; Fabrizi M; Ferlini C; Mozzetti S; De Stefano I; Scambia G
Endocr Relat Cancer; 2007 Jun; 14(2):317-24. PubMed ID: 17639047
[TBL] [Abstract][Full Text] [Related]
37. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
38. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.
Brueggemeier RW; Bhat AS; Lovely CJ; Coughenour HD; Joomprabutra S; Weitzel DH; Vandre DD; Yusuf F; Burak WE
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):145-56. PubMed ID: 11566439
[TBL] [Abstract][Full Text] [Related]
39. Estrogen regulation of thrombospondin-1 in human breast cancer cells.
Hyder SM; Liang Y; Wu J
Int J Cancer; 2009 Sep; 125(5):1045-53. PubMed ID: 19391135
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens.
Wober J; Weisswange I; Vollmer G
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):227-33. PubMed ID: 12650720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
